TY - JOUR
T1 - Epidemiological issues in comorbidity
T2 - lessons learnt from a pan-European ISADORA project
AU - Baldacchino, A.
AU - Groussard-Escaffre, N.
AU - Clancy, C.
AU - Lack, C.
AU - Sieroslavrska, K.
AU - Hodges, C. L.
AU - Merinder, L. B.
AU - Greacen, T.
AU - Sorsa, M.
AU - Laijarvi, H.
AU - Baeck-Moller, K.
PY - 2009
Y1 - 2009
N2 - Aims: This article sets out to identify the issues that are relevant to understanding the current approaches used to determine the extent of the problems as a result of co-existent substance misuse and mental health problems comorbidity 1 in Europe. It is a fundamental prerequisite that it is based on robust epidemiological processes.
Method: This article will describe an attempt to identify current data available in 2002 on the prevalence of co-morbidity per 100,000 inhabitants in Poland (Warsaw), Denmark (Aarhus), Finland (Tampere), England & Wales (London and Cambridge), Scotland (Dundee) and France (Paris) as part of the ISADORA project.
Results: This exercise highlights methodological challenges in the epidemiology of comorbidity such as setting, subjects, intervention used and context, conceptual, units of contents, time window and accuracy of resolution and assessment method used.
Conclusion: These issues need to be resolved before representative information can be interpreted.
AB - Aims: This article sets out to identify the issues that are relevant to understanding the current approaches used to determine the extent of the problems as a result of co-existent substance misuse and mental health problems comorbidity 1 in Europe. It is a fundamental prerequisite that it is based on robust epidemiological processes.
Method: This article will describe an attempt to identify current data available in 2002 on the prevalence of co-morbidity per 100,000 inhabitants in Poland (Warsaw), Denmark (Aarhus), Finland (Tampere), England & Wales (London and Cambridge), Scotland (Dundee) and France (Paris) as part of the ISADORA project.
Results: This exercise highlights methodological challenges in the epidemiology of comorbidity such as setting, subjects, intervention used and context, conceptual, units of contents, time window and accuracy of resolution and assessment method used.
Conclusion: These issues need to be resolved before representative information can be interpreted.
U2 - 10.1080/17523280902930130
DO - 10.1080/17523280902930130
M3 - Article
VL - 2
SP - 88
EP - 100
JO - Mental Health and Substance Use: Dual Diagnosis
JF - Mental Health and Substance Use: Dual Diagnosis
IS - 2
ER -